These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 26612473)

  • 1. Complicated Intra-Abdominal Infections: The Old Antimicrobials and the New Players.
    Lee YR; McMahan D; McCall C; Perry GK
    Drugs; 2015 Dec; 75(18):2097-117. PubMed ID: 26612473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New drugs for the treatment of complicated intra-abdominal infections in the era of increasing antimicrobial resistance.
    Syue LS; Chen YH; Ko WC; Hsueh PR
    Int J Antimicrob Agents; 2016 Apr; 47(4):250-8. PubMed ID: 27005457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ceftolozane/Tazobactam Plus Metronidazole for Complicated Intra-abdominal Infections in an Era of Multidrug Resistance: Results From a Randomized, Double-Blind, Phase 3 Trial (ASPECT-cIAI).
    Solomkin J; Hershberger E; Miller B; Popejoy M; Friedland I; Steenbergen J; Yoon M; Collins S; Yuan G; Barie PS; Eckmann C
    Clin Infect Dis; 2015 May; 60(10):1462-71. PubMed ID: 25670823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New antimicrobial options for the management of complicated intra-abdominal infections.
    Leone S; Damiani G; Pezone I; Kelly ME; Cascella M; Alfieri A; Pace MC; Fiore M
    Eur J Clin Microbiol Infect Dis; 2019 May; 38(5):819-827. PubMed ID: 30903538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial susceptibility of pathogens isolated from patients with complicated intra-abdominal infections at five medical centers in Taiwan that continuously participated in the Study for Monitoring Antimicrobial Resistance Trends (SMART) from 2006 to 2010.
    Lee YL; Chen YS; Toh HS; Huang CC; Liu YM; Ho CM; Lu PL; Ko WC; Chen YH; Wang JH; Tang HJ; Yu KW; Liu YC; Chuang YC; Liu CE; Hsueh PR
    Int J Antimicrob Agents; 2012 Jun; 40 Suppl():S29-36. PubMed ID: 22749056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial susceptibility of gram-negative pathogens isolated from patients with complicated intra-abdominal infections in South African hospitals (SMART Study 2004-2009): impact of the new carbapenem breakpoints.
    Brink AJ; Botha RF; Poswa X; Senekal M; Badal RE; Grolman DC; Richards GA; Feldman C; Boffard KD; Veller M; Joubert I; Pretorius J
    Surg Infect (Larchmt); 2012 Feb; 13(1):43-9. PubMed ID: 22220506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ceftolozane/tazobactam for the treatment of complicated urinary tract and intra-abdominal infections.
    Bassetti M; Righi E
    Future Microbiol; 2015; 10(2):151-60. PubMed ID: 25689527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Challenge of Antimicrobial Resistance in Managing Intra-Abdominal Infections.
    Sartelli M; Catena F; di Saverio S; Ansaloni L; Coccolini F; Tranà C; Kirkby-Bott J
    Surg Infect (Larchmt); 2015 Jun; 16(3):213-20. PubMed ID: 25831090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical characteristics and antimicrobial patterns in complicated intra-abdominal infections: a 6-year epidemiological study in southern China.
    Ouyang W; Xue H; Chen Y; Gao W; Li X; Wei J; Wen Z
    Int J Antimicrob Agents; 2016 Mar; 47(3):210-6. PubMed ID: 26899413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobials: a global alliance for optimizing their rational use in intra-abdominal infections (AGORA).
    Sartelli M; Weber DG; Ruppé E; Bassetti M; Wright BJ; Ansaloni L; Catena F; Coccolini F; Abu-Zidan FM; Coimbra R; Moore EE; Moore FA; Maier RV; De Waele JJ; Kirkpatrick AW; Griffiths EA; Eckmann C; Brink AJ; Mazuski JE; May AK; Sawyer RG; Mertz D; Montravers P; Kumar A; Roberts JA; Vincent JL; Watkins RR; Lowman W; Spellberg B; Abbott IJ; Adesunkanmi AK; Al-Dahir S; Al-Hasan MN; Agresta F; Althani AA; Ansari S; Ansumana R; Augustin G; Bala M; Balogh ZJ; Baraket O; Bhangu A; Beltrán MA; Bernhard M; Biffl WL; Boermeester MA; Brecher SM; Cherry-Bukowiec JR; Buyne OR; Cainzos MA; Cairns KA; Camacho-Ortiz A; Chandy SJ; Che Jusoh A; Chichom-Mefire A; Colijn C; Corcione F; Cui Y; Curcio D; Delibegovic S; Demetrashvili Z; De Simone B; Dhingra S; Diaz JJ; Di Carlo I; Dillip A; Di Saverio S; Doyle MP; Dorj G; Dogjani A; Dupont H; Eachempati SR; Enani MA; Egiev VN; Elmangory MM; Ferrada P; Fitchett JR; Fraga GP; Guessennd N; Giamarellou H; Ghnnam W; Gkiokas G; Goldberg SR; Gomes CA; Gomi H; Guzmán-Blanco M; Haque M; Hansen S; Hecker A; Heizmann WR; Herzog T; Hodonou AM; Hong SK; Kafka-Ritsch R; Kaplan LJ; Kapoor G; Karamarkovic A; Kees MG; Kenig J; Kiguba R; Kim PK; Kluger Y; Khokha V; Koike K; Kok KY; Kong V; Knox MC; Inaba K; Isik A; Iskandar K; Ivatury RR; Labbate M; Labricciosa FM; Laterre PF; Latifi R; Lee JG; Lee YR; Leone M; Leppaniemi A; Li Y; Liang SY; Loho T; Maegele M; Malama S; Marei HE; Martin-Loeches I; Marwah S; Massele A; McFarlane M; Melo RB; Negoi I; Nicolau DP; Nord CE; Ofori-Asenso R; Omari AH; Ordonez CA; Ouadii M; Pereira Júnior GA; Piazza D; Pupelis G; Rawson TM; Rems M; Rizoli S; Rocha C; Sakakushev B; Sanchez-Garcia M; Sato N; Segovia Lohse HA; Sganga G; Siribumrungwong B; Shelat VG; Soreide K; Soto R; Talving P; Tilsed JV; Timsit JF; Trueba G; Trung NT; Ulrych J; van Goor H; Vereczkei A; Vohra RS; Wani I; Uhl W; Xiao Y; Yuan KC; Zachariah SK; Zahar JR; Zakrison TL; Corcione A; Melotti RM; Viscoli C; Viale P
    World J Emerg Surg; 2016; 11():33. PubMed ID: 27429642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The 2018 Lebanese Society of Infectious Diseases and Clinical Microbiology Guidelines for the use of antimicrobial therapy in complicated intra-abdominal infections in the era of antimicrobial resistance.
    Haddad N; Kanj SS; Awad LS; Abdallah DI; Moghnieh RA
    BMC Infect Dis; 2019 Mar; 19(1):293. PubMed ID: 30925909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent developments in antibiotic agents for the treatment of complicated intra-abdominal infections.
    Lin SY; Huang CH; Ko WC; Chen YH; Hsueh PR
    Expert Opin Pharmacother; 2016; 17(3):339-54. PubMed ID: 26610040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [New possibilities in antibacterial treatment of intra-abdominal infections caused by multiresistant microflora].
    Dibirov MD; Khachatryan NN; Isaev AI; Karsotyan GS; Alimova EE; Kostyuk EA
    Khirurgiia (Mosk); 2019; (12):74-83. PubMed ID: 31825346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical challenges and unmet needs in the management of complicated intra-abdominal infections.
    Mazuski JE
    Surg Infect (Larchmt); 2005; 6 Suppl 2():S-49-69. PubMed ID: 23577497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Focus on ceftazidime-avibactam for optimizing outcomes in complicated intra-abdominal and urinary tract infections.
    Nicolau DP
    Expert Opin Investig Drugs; 2015; 24(9):1261-73. PubMed ID: 26145447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ceftolozane/Tazobactam: A Review in Complicated Intra-Abdominal and Urinary Tract Infections.
    Scott LJ
    Drugs; 2016 Feb; 76(2):231-42. PubMed ID: 26746849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of moxifloxacin for the treatment of community-acquired [corrected] complicated intra-abdominal infections in Taiwan.
    Lau YJ; Chen YH; Huang CT; Lee WS; Liu CY; Liu JW; Liu HD; Lee YJ; Chen CW; Ko WC; Hsueh PR
    J Microbiol Immunol Infect; 2012 Feb; 45(1):1-6. PubMed ID: 22244019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Profile of ceftolozane/tazobactam and its potential in the treatment of complicated intra-abdominal infections.
    Skalweit MJ
    Drug Des Devel Ther; 2015; 9():2919-25. PubMed ID: 26082619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current strategies for the treatment of complicated intraabdominal infections.
    Skrupky LP; Tellor BR; Mazuski JE
    Expert Opin Pharmacother; 2013 Oct; 14(14):1933-47. PubMed ID: 23876130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New and Emerging Antibiotics for Complicated Intra-Abdominal Infections.
    Durand CR; Alsharhan M; Willett KC
    Am J Ther; 2017; 24(6):e763-e769. PubMed ID: 26796653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.